Learner Assessment : A Patient Who Was Diagnosed With Hepatitis C.

Teaching-learning session is almost the same to the nursing process that is used in clinical settings (Habel,2006). In the learning process, the initial step is assessment of the learners understanding towards their health condition, which is then followed by the questions what do they need to learn and what will be the appropriate approach to teach them (Habel, 2006).

Being a student in the UW nursing school, I can not only take advantage of the special classroom settings, but also the advanced technology. With classroom settings designed for active learning, it gives me opportunities to share my thoughts and ideas with other students. Instead of listening passively, we would work as a team to find out the best solution for patients. Besides, the unique state-of-the-art technology allows me to practice and apply my knowledge in a simulated hospital setting. Since every practice is recorded, I can take a look at those videos several times and self-reflect. Thus, I can correct my mistakes and improve.

Hepatitis C (HCV) is a disease of the blood, caused by a history of intravenous (IV) drug abuse, blood transfusions received that were infected with HCV prior to 1992 when screening started, healthcare workers suffering from a needle stick, and recipients of donor organs that tested positive for HCV (Lewis, Heitkemper, Dirksen, & Bucher, 2014). A challenge that I have encountered in the office with getting treatment started for a patient is that not everyone in the clinic understands the clinical documentation and tests needed to receive therapy approval. The result of decreased knowledge of HCV treatment is the patient having to return to the clinic two or three times to obtain all required clinical data, which is prolonging the start of treatment. The purpose of this paper is to improve patient satisfaction with their treatment of HCV. I began with my pre-assessment of the novice to expert nurses, by asking them 30 questions. In the assessment, it tested the current knowledge that each individual had on HCV. After obtaining the needed data to come up with a program for the clinic, I was amazed at the different answers. I will be discussing the educational needs for improvement of HCV screenings, listing the questions used in the interview, listing the staff and their titles, listing educational needs I found during my assessment, and discussing what my case study topic will entail.

This research paper is going to review today’s silent killer, the Hepatitis C virus. This paper will talk about the description of the disease, the signs and symptoms, the etiology and risk factors, diagnostic studies, treatments and prognosis of this disease. I had lived with this disease for over ten years before diagnosed so it is important to understand the signs and symptoms so the disease can be identified and a treatment plan can be identified as the sooner it is treated the more likely it will eradicate the disease.

After having a chat with Cinderella she has told me that her social life and circle of friends is quite limited as her income is now much lower. She also mentioned that is quiet difficult to make new friends while you have drug use history. When speaking to Cinderella it became evident to me that being HCV positive makes her feels worse than others and reminds her of when she was using drugs.

“Curricula must be aligned with the practice setting (Veltri, 2012). At this time all staff will be handed out a step by step book with screen shots on how to operate the new EMR. This includes opening a patient’s chart, accessing medications, past medical records, and any progress or clinical notes. To accommodate all different types of learning styles to individuals these training sessions will also be recorded for staff to view multiple times or at any time. “Because the purpose of clinical learning is to foster application of theory to practice, clinical learning activities should be related to what is being taught in the classroom” (Gaberson, 2012). Teaching sessions will be mandatory for all staff and their will be make up classes the next week for the individuals who will be off the days of the sessions. A copy of the step by step booklet will also be emailed a power point presentation that they can save to their desktop so they can reference back if they develop any questions. “The lecture method presents information effectively; creative strategies provide diversions that reinforce key material or area of emphasis” (Herman, 2008). During the week there will be small quizzes staff need to take and receive an 90% or higher to show compensates in the EMR system. If someone fails to achieve this percentage they will attend the class again with another quiz at the end of the day. At the end of the week comprehensive test will be given as well and the same 90% grade. The test is very important as it will ensure that staff is able to chart and document in the appropriate section, know where to find vital information such as medications, past medical and surgeries history. Staff who achieves thee highest percentage will have the opportunity to become “super users”

Michelle told us both that she would like me to fill the position of Hepatitis C specialist, a part-time position which would include public education, case management, and forming a Hepatitis C support group. I was stunned. How could I be a Hepatitis C specialist when I was not even knowledgeable about the disease? Michelle said she would give me three months to educate myself, attend lectures, pharmaceutical presentations, and create my own power point presentation to present to the staff of the McDowell Clinic and Body Positive. I would also be responsible to seek out all the physicians that specialized in treating Hepatitis C and introducing myself to them. I just prayed that when she introduced me as a specialist, no one would ask me a question. Luckily no one

About 4.1 million people in Americans have the positive antibody to hepatitis C virus (HCV), and about 75 percent have permeant infection. Additionally, most of the infections happened 20 to 40 years ago, before the finding of HCV. Hepatitis C increased from 7,000 to 13,000 deaths in 2005. Furthermore, HCV develops slowly which increases the risk of severe complications in the infected people. Identification, death, and treatment are predicted to affect 35,000 by 2030. The Center for Disease Control (CDC) used antiviral therapy with PEGylated in clinical trials (Kalichman, Washington, Kegler, Grebler, Kalichman, Cherry, & Eaton, 2015). The CDC recommends a HCV one time test for people born between 1945 and 1965. The objective of this study was to thoroughly evaluate the amount of substance abusers infected with hepatitis C in the United States. Additionally, to observe the treatment of HCV. Currently Medicaid and Medicare repayment standards for sofosbuvir were calculated in all states, including the District of Columbia. Medicaid and Medicare covered the drug based on the following conditions; liver disease stage, HIV, and drug use. Approximately 42 states reimbursed the following criteria up to 74 percent for the drug sofobuvir. About two-thirds of the United States restricted the treatment centered on prescriber type. About 88 percent included drug abuse in their sofosbuvir admissibility measures. Finally, 50 percent required a date of abstinence and 64 percent required

According to Baily, et al. (2009) lack of treatment to cure the disease will lead to a patient’s uncertainty on how the illness will present itself in the future. Thus, patients must face the unknown factors of their disease progression and manage life with their chronic illness. In Chronic Hepatitis C, tracking of outcomes and progressions are difficult, and disease trajectory varies from person to person (Baily, et al 2009). In addition, uncertainty stems from lack of knowledge of the disease, loss of control, and expectations of possible relapse of symptoms in the future.

Recall the dreaded trips to the doctor’s office when it was time to get shots. These shots are vaccines, which provide immunity to certain diseases. You received vaccines for Tetanus, Hepatitis B, Measles and Polio. A vaccine you did not get though, is one for Hepatitis C. Hepatitis C is a disease that affects the way the liver operates, and although there is a vaccine for both Hepatitis A and B, there is not one for C. Hepatitis C affects the digestive system, more specifically the liver. It can also damage the central nervous system and the circulatory system. Blood tests are the most common way to detect Hepatitis C and after one has been diagnosed with it, there are many ways to treat it. Hepatitis C is a treatable disease with varying

Hepatitis C is a blood transmitted virus that has been know for substandard therapies/ drug treatments. When Mr. Parish commented that currently, there is no absolute cure to HCV, my mind immediately shifted to “cancer”. People often think of cancer as the most severe illness someone can get, because there is no cure. However, we forget that in actuality, there are numerous

Hepatitis C is a prevalent health care problem. According to the Centers of Disease Control and Prevention (CDC, 2016), approximately 2.7-3.9 million of the adult population in the United States is infected with hepatitis C virus (HCV). Some groups of people are at risk for Hepatitis C infection, including current injection drug users, people who received the blood transfusion before 1992, organ recipients from a donor who tested positive for hepatitis C virus, hemodialysis patients, and children born to a hepatitis C mother (CDC, 2016). Hepatitis C causes embarrassment and isolation from the society. Self-esteem and understanding of the

Hepatitis C has been referred to as a "Silent Epidemic," since it usually progresses slowly over many years. Most people who are infected with hepatitis C are not aware of any noticeable symptoms for as long as one to two decades after they are infected. In fact, by the time symptoms appear, the virus has probably already begun to damage the liver. If the liver is injured and stops functioning, death will always be the outcome (Lieber). Liver failure from chronic hepatitis C is one of the most common causes of liver transplants in the United States.

Chronic hepatitis C (HCV) is a common infection in injecting drug users and the prevalence of HCV infection in this subpopulation is up to 60% (ROUX). Patients with infective endocarditis (IE) are at higher risk of developing neurological complications such as cardioembolic stroke. In 10-50% of patients with IE in the left heart, it may cause stroke, usually in the first two weeks of illness. (GRECU) According to the latest recommendations the IE is diagnosed on the basics of transthoracic and transesophageal echocardiography (HORSTKOTTE) but doubts of IE can be set on the basis of Doppler ultrasonography of the carotid arteries and observed changes in blood flow through the arteries that can indicate changes in the valves that may exist within

I agree with you, demonstration and return demonstration instructional method of learning is very effective in hospital setting. The best options for patient is learning from health care providers not from internet “providers” Dr google or “You Tube”. According to Burbridge (2014), “patients and other care givers should be very skeptical of the value of You Tube videos demonstrating medical techniques “ ,because is not easy determine if these videos are from reputable websites.